110 related articles for article (PubMed ID: 13511673)
1. Sodium polyethylene sulfonate; effects on serum lipids and blood coagulation.
KUO PT; HOPKINS FT; WURZEL H
Circ Res; 1958 Mar; 6(2):178-84. PubMed ID: 13511673
[No Abstract] [Full Text] [Related]
2. Synthesis and nonthrombogenicity of polyetherurethaneurea film grafted with poly(sodium vinyl sulfonate).
Ito Y; Iguchi Y; Kashiwagi T; Imanishi Y
J Biomed Mater Res; 1991 Nov; 25(11):1347-61. PubMed ID: 1797807
[TBL] [Abstract][Full Text] [Related]
3. Synthetic thromboresistant surfaces from sulfonated polyelectrolyte complexes.
Nelsen L; Cross RA; Vogel MA; Gott VL; Fadali AM
Surgery; 1970 May; 67(5):826-30. PubMed ID: 5438682
[No Abstract] [Full Text] [Related]
4. Sodium polyethylene sulfonate: tissue distribution and effect on C-14-1-palmitic acid oxidation.
MILLER WL; KRAKE JJ
Proc Soc Exp Biol Med; 1962 Jun; 110():309-11. PubMed ID: 14474120
[No Abstract] [Full Text] [Related]
5. [Antilipemic and non-anticoagulant decomposition product of heparin].
ZOLLNER N; ROTHEMUND E; SEITZ W
Klin Wochenschr; 1954 Dec; 32(45-46):1096-7. PubMed ID: 13234288
[No Abstract] [Full Text] [Related]
6. [Evaluation of the effect of subcutaneous heparin on blood coagulability and blood lipids in diabetic patients].
Ghanem MH; Tawfik S; Guirgis FK; el-Sawy M
Therapeutique; 1971 May; 47(5):473-6. PubMed ID: 5562482
[No Abstract] [Full Text] [Related]
7. [Indicators of blood coagulation and serum lipids after food loading and heparin administration].
Malanowicz W; Zambrowicz K; Tenenbaum B
Pol Arch Med Wewn; 1968; 40(5):591-8. PubMed ID: 5661499
[No Abstract] [Full Text] [Related]
8. [Study of the antilipemic and anticoagulant activity of a heparin derivative].
REGAZZINI A; RODARI T
Rass Fisiopatol Clin Ter; 1961 Apr; 33():301-16. PubMed ID: 14491056
[No Abstract] [Full Text] [Related]
9. [Effect of heparin on blood lipolytic and coagulation activity in patients with hypertensive disease].
Oleĭnik NI
Klin Med (Mosk); 1969 Jul; 47(7):75-9. PubMed ID: 5385094
[No Abstract] [Full Text] [Related]
10. [Dose-response relations of N-formyl-chitosan-polysulfuric acid ester (Ro 1-8307) in regard to the activation of the clearing factor & inhibition of coagulation in comparison with heparin in animal experiments & in man].
REBER K; STUDER A; TOBLER R; KOLLER F
Acta Haematol; 1959 Jan; 21(1):31-5. PubMed ID: 13626505
[No Abstract] [Full Text] [Related]
11. Interaction of poly(sodium vinyl sulfonate) and its surface graft with antithrombin III.
Ito Y; Liu LS; Imanishi Y
J Biomed Mater Res; 1991 Jan; 25(1):99-115. PubMed ID: 2019613
[TBL] [Abstract][Full Text] [Related]
12. [Cyclonamine ethamsilate in the treatment of atherosclerotic vascular diseases in the senile age, with spcial reference to the blood lipid level].
Volterrani U; Baiotti G
Minerva Med; 1970 Nov; 61(91):5185-94. PubMed ID: 5496158
[No Abstract] [Full Text] [Related]
13. [Investigation on certain physicochemical properties of a polymethylenecreosol-sulfonic acid (acidosept) and its effect upon blood coagulation].
GIDDEY C; FREY E; CHERBULIEZ E
Pharm Acta Helv; 1951 Apr; 26(4):139-43. PubMed ID: 14875475
[No Abstract] [Full Text] [Related]
14. [Serum lipids following experimental fibrinolysis].
Suschke J; Kunze D; von Pilar CE; Krejci K
Monatsschr Kinderheilkd (1902); 1973 Jul; 121(7):388-9. PubMed ID: 4270871
[No Abstract] [Full Text] [Related]
15. [The effect of sodium aspartate on some serum protease activities and lipid components in dogs].
Tomuş L; Suciu A; Rosenfeld E; Cordoş D
Fiziol Norm Patol; 1972; 18(2):133-44. PubMed ID: 5032188
[No Abstract] [Full Text] [Related]
16. [Considerations on the changes of the coagulation and fibrinolytic picture and of uricemia during therapy with heparin in low doses. Relations with the change of the lipemic level].
Lombardi V; Bonini M
Minerva Med; 1970 Oct; 61(87):4889-92. PubMed ID: 5488539
[No Abstract] [Full Text] [Related]
17. Morning vs evening effects of intrapulmonary administration of heparin in healthy men.
Markiewicz A; Tausz B; Zahorska-Markiewicz B; Nawrot J
Int J Clin Pharmacol Ther Toxicol; 1992 Oct; 30(10):400-4. PubMed ID: 1446957
[TBL] [Abstract][Full Text] [Related]
18. Effect of an anionic polyelectrolyte (polyethylene sulfonate) in patients with cancer. Clinical pharmacology of a macromolecule.
REGELSON W; HOLLAND JF
Clin Pharmacol Ther; 1962; 3():730-49. PubMed ID: 13973638
[No Abstract] [Full Text] [Related]
19. Nonthrombogenic materials via a simple coating process.
Grode GA; Anderson SJ; Grotta HM; Falb RD
Trans Am Soc Artif Intern Organs; 1969; 15():1-6. PubMed ID: 5791389
[No Abstract] [Full Text] [Related]
20. [Influence of sodium salicylate, acetylsalicylate, 2, 3-dihydroxybenzoic and 2, 3-diacetoxybenzoic acids on the blood coagulation system and the elimination of heparin].
Ermakova NV
Farmakol Toksikol; 1975; 38(4):445-9. PubMed ID: 1213133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
